Product Details-
| Composition | Cefpodoxime 200mg Clavulanate Acid 125mg |
|---|---|
| Dosage | TABLET |
| Packing Size | 10x1x10 |
| Packing | Strip |
Sefokure CV 325 is an advanced antibiotic formulation that combines Cefpodoxime 200mg with Clavulanic Acid 125 mg. This dual-action blend provides superior effectiveness against a wide spectrum of Gram-positive and Gram-negative bacteria, especially those resistant to single-drug antibiotics.
Sefokure CV 325 is trusted by physicians for its high efficacy, safety, and faster recovery rate in bacterial infections of the respiratory, urinary, ENT, and gastrointestinal tracts.
Each tablet of Sefokure CV 325 contains:
Cefpodoxime 200mg – A second-generation cephalosporin antibiotic
Clavulanic Acid 125 mg – A beta-lactamase inhibitor that protects Cefuroxime from degradation
This synergistic formulation enhances antibiotic activity and treats beta-lactamase producing resistant bacteria effectively.
Sefokure CV 325 works through two mechanisms:
Cefpodoxime 200mg disrupts bacterial cell wall synthesis, leading to bacterial cell death
Clavulanic Acid inhibits the beta-lactamase enzyme secreted by resistant bacteria, preventing Cefuroxime breakdown
This dual action ensures enhanced bacterial killing, even in resistant infections.
Sefokure CV 325 is used in the treatment of:
Upper respiratory tract infections (tonsillitis, pharyngitis, sinusitis)
Lower respiratory tract infections (bronchitis, pneumonia)
Urinary tract infections (UTIs)
Skin and soft tissue infections
Ear infections (otitis media)
Dental infections
Gastrointestinal infections including typhoid fever
Its broad coverage makes Sefokure CV 325 a preferred choice across medical practices.
Usual adult dose: 1 tablet twice daily (every 12 hours) or as directed by a doctor
Best taken after food for better absorption
Course duration: 5–10 days depending on infection severity
Do not skip doses or discontinue prematurely
Completing the full course of Sefokure CV 325 is essential to prevent antibiotic resistance and ensure full recovery.
Broad-spectrum protection against resistant and sensitive strains
Enhanced antibiotic stability with Clavulanic Acid
Faster symptom relief and recovery
Safe for both acute and chronic infections
Effective in community-acquired and hospital-acquired infections
Clinically tested and approved by healthcare professionals
When resistance is a concern, Sefokure CV 325 delivers uncompromising efficacy.
Avoid Sefokure CV 325 if:
You have a history of allergy to penicillins or cephalosporins
You suffer from severe renal impairment without dose adjustment
You have a history of antibiotic-associated colitis
Use with caution in:
Pregnant or breastfeeding women (only under doctor’s advice)
Patients with liver disease or prolonged antibiotic use
Most side effects are mild and temporary:
Nausea or vomiting
Diarrhea
Headache
Skin rash or itching
Abdominal discomfort
Dizziness
Rare but serious side effects include:
Severe allergic reactions (anaphylaxis)
Hepatic dysfunction
Pseudomembranous colitis
If you notice any severe or prolonged symptoms, consult your physician immediately.
Sefokure CV 325 may interact with:
Probenecid – Increases Cefuroxime levels in the body
Oral contraceptives – May reduce effectiveness
Antacids or H2-blockers – May interfere with absorption
Blood thinners (Warfarin) – Monitor INR levels if used concurrently
Always inform your doctor of any current medications before starting Sefokure CV 325.
Pediatrics: Not recommended in this strength; pediatric-specific doses are advised
Pregnancy: Use if clearly needed and prescribed by a healthcare provider
Lactation: May be used with caution
Elderly: Safe with monitoring, especially in renal impairment
Store in a cool, dry place below 25°C
Protect from moisture and direct sunlight
Keep out of reach of children
Do not use after expiry date
Proper storage maintains the stability and potency of Sefokure CV 325.
Take after meals for optimal absorption
Hydrate well during the antibiotic course
Avoid alcohol and smoking
Complete the prescribed course
Inform your doctor of any previous drug allergies
Consistency and adherence to your dosing schedule are key to maximum effectiveness of Sefokure CV 325.
Sefokure CV 325 is a potent antibiotic combination of Cefpodoxime 200mg and Clavulanic Acid 125 mg, offering broad-spectrum coverage and resistance protection. Its dual-action mechanism fights even beta-lactamase producing bacteria, ensuring successful treatment of ENT, respiratory, urinary, and skin infections.
With its proven efficacy, safety profile, and powerful formulation, Sefokure CV 325 stands out as a smart choice for infection management.